#WhyIDidntReport Is A Gut-Wrenching Response To Trump’s Attack on Ford’s Credibility
Ting Shen/ZUMA Looking for news you can trust?Subscribe to our free newsletters. For the first time since Christine Blasey Ford came forward with sexual assault allegations against Brett Kavanaugh, President Donald Trump on Friday openly suggested that Ford’s account may not be credible—a clear end to the uncharacteristically measured response Trump had initially taken after…
A Coal Ash Spill After Florence Could Contaminate a Major River
Tom Copeland/AP Looking for news you can trust?Subscribe to our free newsletters. Over several days, Hurricane Florence dropped more than three feet of rain on North Carolina, flooding towns and neighborhoods and threatening the environmental safety of the waterways weaving through the state. On Friday, Duke Energy reported that a dam at its Wilmington power…
Lousy Patent Examiners Prefer Working in the Private Sector
Sure, you can patent flavored water with vitamins added to it. I don’t see why not.The Coca-Cola Company Looking for news you can trust?Subscribe to our free newsletters. Here’s something odd. It turns out that some patent examiners approve more patents than others. These easy-to-please examiners are subsequently more likely to leave the Patent Office…
The Kavanaugh Affair Careened Off a Cliff Today
Looking for news you can trust?Subscribe to our free newsletters. Today has been beyond bizarre. The allegations by Christine Blasey Ford of attempted rape against Brett Kavanaugh continued to play out, but then in the late afternoon the whole story careened completely over a cliff. I am, literally, almost afraid to write about it, so…
Diversity Is Important to Viewers—With or Without an Emmy
Mother Jones illustration Looking for news you can trust?Subscribe to our free newsletters. When the 70th Primetime Emmy Awards aired this week, it almost seemed as if the event could be a win for diversity. More people of color have been nominated for awards this year than ever before, and the show did not shy away…
Why Are There So Few Blacks in Clinical Trials of Cancer Drugs?
Waltraud Grubitzsch/DPA via ZUMA Looking for news you can trust?Subscribe to our free newsletters. Today brings two related articles that are right up my alley: they’re about possible new cures for multiple myeloma and other cancers. The first, by Ezekiel Emanuel, is about CAR-T treatments, in which cells are removed from your body, genetically altered,…